Dr Reddy's Profit Rises 32%
Linkedin

Dr Reddy's Profit Rises 32%

Bangalore : India | Oct 30, 2012 at 11:08 AM PDT
Source: Asian Wall Street Journal
XX XX
Views: Pending
 
Tuesday reported a better-than-expected 32% increase in its fiscal second quarter net profit thanks to the strong performance of its pharmaceutical services and U.S. generic drugs businesses. Consolidated net profit for the three months ended Sept. 30 rose to 4.07 billion rupees ($75 million)... FULL ARTICLE AT Asian Wall Street Journal
Back
1 of 4
Next
Philips said its profit was based on a 12 percent rise in sales over the last year
Philips said its profit was based on a 12 percent rise in sales over the last year
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
Advertisement
 
Advertisement
 

News Stories

 
  • Reddyi¿½s will take complex generics to Europe

    Daily News & Analysis
    Dr Reddy's Laboratories is reworking its strategy for the European market, where it has a significant operation through German arm Betapharm. The European market has largely moved to a tender-based system with pharmaceutical companies participating...

Images

 >
 

More From Allvoices

 
Tap_logo_330_110_event
 


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.